ATE412747T1 - Neues tumor-antigen-protein sart-3 und tumor- antigen-peptid davon - Google Patents
Neues tumor-antigen-protein sart-3 und tumor- antigen-peptid davonInfo
- Publication number
- ATE412747T1 ATE412747T1 AT99940508T AT99940508T ATE412747T1 AT E412747 T1 ATE412747 T1 AT E412747T1 AT 99940508 T AT99940508 T AT 99940508T AT 99940508 T AT99940508 T AT 99940508T AT E412747 T1 ATE412747 T1 AT E412747T1
- Authority
- AT
- Austria
- Prior art keywords
- tumor antigen
- new
- antigen protein
- peptide
- protein sart
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24266098 | 1998-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412747T1 true ATE412747T1 (de) | 2008-11-15 |
Family
ID=17092354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99940508T ATE412747T1 (de) | 1998-08-28 | 1999-08-27 | Neues tumor-antigen-protein sart-3 und tumor- antigen-peptid davon |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US7541428B2 (de) |
| EP (1) | EP1116791B1 (de) |
| JP (2) | JP4436977B2 (de) |
| KR (1) | KR100660367B1 (de) |
| CN (1) | CN1264980C (de) |
| AT (1) | ATE412747T1 (de) |
| AU (1) | AU762516B2 (de) |
| CA (1) | CA2340888C (de) |
| DE (1) | DE69939833D1 (de) |
| ES (1) | ES2316191T3 (de) |
| HK (1) | HK1041290B (de) |
| ID (1) | ID29405A (de) |
| NZ (1) | NZ510154A (de) |
| WO (1) | WO2000012701A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1116791B1 (de) * | 1998-08-28 | 2008-10-29 | Kyogo Itoh | Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon |
| JP2002365286A (ja) * | 2000-11-13 | 2002-12-18 | Kyogo Ito | 細胞性免疫検出法およびその医薬への応用 |
| CA2476995A1 (en) | 2001-09-18 | 2003-03-27 | Kyogo Itoh | Method of detecting cellular immunity and application thereof to drugs |
| CA2534461A1 (en) * | 2003-08-05 | 2005-02-10 | Green Peptide Co., Ltd | An agent for preventing and/or treating hematologic malignancies |
| CA2538300A1 (en) * | 2003-09-22 | 2005-03-31 | Green Peptide Co., Ltd. | Prognosis in cancer patients vaccinated with a cancer antigen peptide-associated agent |
| JP5114403B2 (ja) * | 2006-07-11 | 2013-01-09 | 株式会社グリーンペプタイド | Ｈｌａ−ａ３スーパータイプアレル陽性前立腺癌患者に対する癌ワクチン療法に有用なｓａｒｔ３由来ペプチド |
| CA2927770C (en) * | 2007-09-18 | 2017-09-19 | Green Peptide Co., Ltd. | Ctl inducer composition |
| CA2804127A1 (en) | 2010-07-07 | 2012-01-12 | Green Peptide Co., Ltd. | Cancer peptide vaccine |
| MX2015011257A (es) | 2013-03-08 | 2015-11-16 | Taiho Pharmaceutical Co Ltd | Peptido novedoso que tiene 5 epitopos de linfocitos t citotoxicos enlazados. |
| PT3061771T (pt) * | 2013-10-21 | 2020-05-06 | Taiho Pharmaceutical Co Ltd | Novo péptido unido a quatro epitopos ctl |
| US20210236613A1 (en) | 2018-06-29 | 2021-08-05 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent and evaluation method thereof |
| KR20220120627A (ko) | 2019-12-26 | 2022-08-30 | 다이호야쿠힌고교 가부시키가이샤 | 수술 후 보조 요법제 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09502086A (ja) * | 1993-08-06 | 1997-03-04 | サイテル コーポレイション | 完全ｍａｇｅ１遺伝子のクローニング及び特性決定 |
| WO1997046676A1 (fr) | 1996-06-07 | 1997-12-11 | Kyogo Itoh | Proteines d'antigenes tumoraux, genes derives de ces proteines, et peptides d'antigenes tumoraux |
| EP1116791B1 (de) * | 1998-08-28 | 2008-10-29 | Kyogo Itoh | Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon |
| CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| US20060035251A1 (en) | 2004-06-30 | 2006-02-16 | Whitehead Institute For Biomedical Research | Novel methods for high-throughput genome-wide location analysis |
-
1999
- 1999-08-27 EP EP99940508A patent/EP1116791B1/de not_active Expired - Lifetime
- 1999-08-27 KR KR1020017002677A patent/KR100660367B1/ko not_active IP Right Cessation
- 1999-08-27 AT AT99940508T patent/ATE412747T1/de not_active IP Right Cessation
- 1999-08-27 DE DE69939833T patent/DE69939833D1/de not_active Expired - Lifetime
- 1999-08-27 ES ES99940508T patent/ES2316191T3/es not_active Expired - Lifetime
- 1999-08-27 JP JP2000567688A patent/JP4436977B2/ja not_active Expired - Lifetime
- 1999-08-27 WO PCT/JP1999/004622 patent/WO2000012701A1/ja active IP Right Grant
- 1999-08-27 NZ NZ510154A patent/NZ510154A/xx unknown
- 1999-08-27 CA CA002340888A patent/CA2340888C/en not_active Expired - Lifetime
- 1999-08-27 CN CNB998125962A patent/CN1264980C/zh not_active Expired - Lifetime
- 1999-08-27 ID IDW20010447A patent/ID29405A/id unknown
- 1999-08-27 AU AU54441/99A patent/AU762516B2/en not_active Ceased
-
2002
- 2002-04-15 HK HK02102831.7A patent/HK1041290B/zh not_active IP Right Cessation
-
2004
- 2004-02-20 US US10/781,659 patent/US7541428B2/en not_active Expired - Fee Related
-
2009
- 2009-04-29 US US12/432,700 patent/US7968676B2/en not_active Expired - Fee Related
- 2009-09-11 JP JP2009210191A patent/JP4904384B2/ja not_active Expired - Lifetime
-
2011
- 2011-05-17 US US13/109,976 patent/US8097697B2/en not_active Expired - Fee Related
- 2011-12-14 US US13/326,304 patent/US8563684B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69939833D1 (de) | 2008-12-11 |
| ID29405A (id) | 2001-08-30 |
| US7541428B2 (en) | 2009-06-02 |
| AU5444199A (en) | 2000-03-21 |
| EP1116791A4 (de) | 2002-01-09 |
| KR100660367B1 (ko) | 2006-12-21 |
| KR20010074895A (ko) | 2001-08-09 |
| EP1116791A1 (de) | 2001-07-18 |
| US7968676B2 (en) | 2011-06-28 |
| CA2340888A1 (en) | 2000-03-09 |
| CA2340888C (en) | 2008-08-05 |
| JP4904384B2 (ja) | 2012-03-28 |
| US20120123090A1 (en) | 2012-05-17 |
| WO2000012701A1 (fr) | 2000-03-09 |
| ES2316191T3 (es) | 2009-04-01 |
| US8563684B2 (en) | 2013-10-22 |
| US20110243974A1 (en) | 2011-10-06 |
| HK1041290A1 (en) | 2002-07-05 |
| CN1324404A (zh) | 2001-11-28 |
| EP1116791B1 (de) | 2008-10-29 |
| HK1041290B (zh) | 2007-03-09 |
| JP4436977B2 (ja) | 2010-03-24 |
| JP2010029194A (ja) | 2010-02-12 |
| US20090297544A1 (en) | 2009-12-03 |
| US20060140968A1 (en) | 2006-06-29 |
| NZ510154A (en) | 2002-11-26 |
| US8097697B2 (en) | 2012-01-17 |
| AU762516B2 (en) | 2003-06-26 |
| CN1264980C (zh) | 2006-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69937294D1 (de) | Von cyclophilin b abstammende tumorantigen-peptide | |
| ATE197307T1 (de) | Neuroaktive peptide | |
| TW581808B (en) | Compounds for immunotherapy of prostate cancer and methods for their use | |
| BR9908823A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
| CY1114164T1 (el) | Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου | |
| CY1106806T1 (el) | Dna και πολυπεπτιδια ανθρωπινης tslp | |
| ITTO950367A0 (it) | Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti. | |
| NZ521396A (en) | Fusion proteins comprising two or more Neisseria polypeptides | |
| NZ516381A (en) | Lung tumor proteins in the therapy and diagnosis of lung cancer | |
| HK1049848A1 (zh) | 用於治療和診斷肺癌的化合物和方法 | |
| DE69939833D1 (de) | Neues tumor-antigen-protein sart-3 und tumor-antigen-peptid davon | |
| EP0911397A4 (de) | Tumorantigenproteine, deren gene, sowie tumorantigenpeptide | |
| ATE397081T1 (de) | Erhöhte expression von proteinen mittels gfp | |
| DE69704269D1 (de) | Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung | |
| WO2001029220A3 (en) | Mage-a12 antigenic peptides and uses thereof | |
| CY1105820T1 (el) | Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις | |
| DE69930942D1 (de) | Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt | |
| ATE356144T1 (de) | Regulatorische/entfaltende peptide von ezrin | |
| DE69815828D1 (de) | Verwendung von mikropartikeln, auf denen ein protein und ein antikörper adsorbiert sind, zur herstellung eines arzneimittels zur intranasalen verabreichung | |
| EP2003201A3 (de) | Verbindungen und Verfahren für Therapie und Diagnose von Lungenkrebs | |
| WO2003044160A3 (en) | Novel molecules of the card related protein family and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |